Advanced Search

2022 Vol. 4, No. 13

Preplanned Studies
Geographic Variation in Cardiovascular Health as Analyzed from the China Cardiovascular Health Index Study — 31 PLADs, China, 2017–2021
Fan Mao, Yingying Jiang, Jing Liu, Yan Zhang, Yong Jiang, Linhong Wang, Dong Zhao, Yong Huo, Junbo Ge, Maigeng Zhou
2022, 4(13): 265-270. doi: 10.46234/ccdcw2022.067
Abstract(5738) HTML (477) PDF 276KB(43)
Abstract:
What is already known about this topic?

The prevalence of cardiovascular disease (CVD) in China is high, while effective prevention and proper management is lacking. No available indicators were found before 2016 that could comprehensively evaluate different aspects of CVD prevention and treatment.

What is added by this report?

Constructed by combining data from multiple dimensions, China cardiovascular health index (CHI) has provided a practical indicator for each provincial-level administrative division (PLAD) to comprehensively understand its overall level and rankings of the specific dimensions of cardiovascular health.

What are the implications for public health practice?

The CHI will be beneficial for each PLAD to identify weak aspects in CVD control and prevention and redistribute resources to the most needed areas.

Vital Surveillances
National Cancer Data Linkage Platform of China: Design, Methods, and Application
Hongmei Zeng, Yunning Liu, Lijun Wang, Peng Yin, Baohua Wang, Ruiying Fu, Xianhui Ran, Rongshou Zheng, Siwei Zhang, Jiangmei Liu, Jinling You, Kexin Sun, Shaoming Wang, Li Li, Ru Chen, Wenqiang Wei, Maigeng Zhou, Jing Wu, Jie He
2022, 4(13): 271-275. doi: 10.46234/ccdcw2022.068
Abstract(5362) HTML (268) PDF 306KB(29)
Abstract:
Background

The National Cancer Center (NCC) and China CDC cooperatively designed a National Cancer Data Linkage (NCDL) Platform to fulfill the task of sharing cancer outcome data through an automatic web-based system.

Methods

NCC and China CDC established a web-based NCDL Platform to link death information from China CDC with the cancer database from NCC. Overall, 76,708 cancer patients’ data were analyzed to assess the feasibility and match rate of the NCDL Platform for 7 major cancers.

Results

The function of the platform includes a data application and approval system, data linkage module, and results visualization system. Through the platform, 38.9% cases were identified as deaths cases from the NCDL Platform in the first 3 years after cancer diagnosis. The linkage rate was highest in liver cancer and lowest in breast cancer.

Conclusions

The NCDL Platform provides a powerful and efficient way to link national vital statistics with national cancer programs’ data. Expanding cancer outcome data linkage may not only improve data collection efficiency, but also improve data use.

Healthy China
Commentary